Approval · Notice of Compliance 11743 · 2010
COVERSYL PLUS: Notice of Compliance 11743
Issued September 27, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11743
- Date
- September 27, 2010
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Angiotensin converting enzyme inhibitor / Diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVERSYL PLUS | 02357321 | Cancelled Pre Market |
| COVERSYL PLUS LD | Not yet assigned | — |
Medicinal ingredients
- PERINDOPRIL ARGININE 10 MG per TAB
- INDAPAMIDE 2.5 MG per TAB
- PERINDOPRIL ARGININE 2.5 MG per TAB
- INDAPAMIDE 0.625 MG per TAB